We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+9.35%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.08B
AUM Growth
+$298M
Cap. Flow
+$91.4M
Cap. Flow %
2.97%
Top 10 Hldgs %
29.39%
Holding
2,686
New
1,350
Increased
669
Reduced
478
Closed
12

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$11.9M
2
PEP icon
PepsiCo
PEP
+$6.06M
3
NVDA icon
NVIDIA
NVDA
+$5.4M
4
MSFT icon
Microsoft
MSFT
+$4.52M
5
UNH icon
UnitedHealth
UNH
+$3.85M

Top Sells

Rank Stock Value
1
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$8.26M
2
HDB icon
HDFC Bank
HDB
+$4.53M
3
HSBC icon
HSBC
HSBC
+$4.45M
4
IBN icon
ICICI Bank
IBN
+$3.79M
5
BHP icon
BHP
BHP
+$2.29M

Sector Composition

Rank Sector Weight
1 Technology 23.23%
2 Financials 12.32%
3 Consumer Discretionary 8.41%
4 Healthcare 7.24%
5 Industrials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBLA icon
2051
Taboola.com
TBLA
$1.35B
$14.6K ﹤0.01%
+4,270
New +$14.6K
AVDL
2052
DELISTED
Avadel Pharmaceuticals
AVDL
$14.5K ﹤0.01%
+949
New +$12.3K
FRHC icon
2053
Freedom Holding
FRHC
$9.95B
$14.5K ﹤0.01%
+84
New +$14.2K
JBSS icon
2054
John B. Sanfilippo & Son
JBSS
$978M
$14.4K ﹤0.01%
+224
New +$14.5K
IE icon
2055
Ivanhoe Electric
IE
$1.47B
$14.3K ﹤0.01%
+1,142
New +$11.3K
PCRX icon
2056
Pacira BioSciences
PCRX
$1.04B
$14.3K ﹤0.01%
+555
New +$13.6K
GO icon
2057
Grocery Outlet
GO
$932M
$14.3K ﹤0.01%
+889
New +$14.2K
ADMA icon
2058
ADMA Biologics
ADMA
$1.97B
$14.3K ﹤0.01%
972
-15,688
-94% -$269K
SENEA icon
2059
Seneca Foods Class A
SENEA
$1.13B
$14.2K ﹤0.01%
+132
New +$14K
LFCR icon
2060
Lifecore Biomedical
LFCR
$163M
$14.2K ﹤0.01%
+1,930
New +$14.6K
CNS icon
2061
Cohen & Steers
CNS
$4.17B
$14K ﹤0.01%
+214
New +$15.7K
WRLD icon
2062
World Acceptance Corp
WRLD
$909M
$14K ﹤0.01%
+83
New +$14K
DLX icon
2063
Deluxe
DLX
$1.22B
$14K ﹤0.01%
+723
New +$13.2K
PI icon
2064
Impinj
PI
$3.97B
$13.9K ﹤0.01%
+77
New +$12.1K
FSV icon
2065
FirstService
FSV
$6.45B
$13.9K ﹤0.01%
+73
New +$14.1K
ALLT icon
2066
Allot
ALLT
$373M
$13.8K ﹤0.01%
+1,306
New +$11.1K
PRO
2067
DELISTED
PROS Holdings
PRO
$13.8K ﹤0.01%
+602
New +$9.79K
IBEX icon
2068
IBEX
IBEX
$467M
$13.8K ﹤0.01%
+340
New +$10.8K
INTA icon
2069
Intapp
INTA
$2.27B
$13.7K ﹤0.01%
+336
New +$14.5K
TNDM icon
2070
Tandem Diabetes Care
TNDM
$1.18B
$13.7K ﹤0.01%
+1,132
New +$15.3K
URGN icon
2071
UroGen Pharma
URGN
$2.02B
$13.7K ﹤0.01%
+688
New +$12.4K
LYFT icon
2072
Lyft
LYFT
$5.73B
$13.7K ﹤0.01%
+623
New +$10.4K
XPEL icon
2073
XPEL
XPEL
$1.18B
$13.7K ﹤0.01%
+413
New +$14.7K
BFAM icon
2074
Bright Horizons
BFAM
$4.1B
$13.5K ﹤0.01%
+124
New +$14.4K
LAZ icon
2075
Lazard
LAZ
$4.23B
$13.5K ﹤0.01%
+255
New +$13.8K

Similar funds

Quadrant Capital Group's Q3 2025 Portfolio in Review

As of Q3 2025, Quadrant Capital Group held 2,686 positions worth $3.08B, up 11% from $2.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Quadrant Capital Group's Q3 2025 filing shows 1,350 new, 669 increased, 478 reduced and 12 closed positions. Its largest new stake was Coupang: 57,787 shares worth $1.86M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $8.26M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Quadrant Capital Group's largest Q3 2025 buy was Coupang: 57,787 shares worth $1.86M.
  • Quadrant Capital Group added most to Apple in Q3 2025, an estimated $11.9M increase.
  • Quadrant Capital Group's biggest Q3 2025 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $8.26M.
  • Quadrant Capital Group fully exited Ansys in Q3 2025, selling an estimated $891K.
  • Quadrant Capital Group's ten largest holdings make up 29% of its $3.08B portfolio in Q3 2025.
  • Quadrant Capital Group opened 1,350 new positions and closed 12 in Q3 2025.
  • Quadrant Capital Group's portfolio value rose 11% quarter-over-quarter to $3.08B.

Based on Quadrant Capital Group's 13F filing for Q3 2025, filed 13 Nov 2025.